Table 2. Univariate logistic regression analyses with the dependent variable ‘signs of pneumonia’.
Independent variable | Odds ratio (95% interval) | p-value | |
---|---|---|---|
Potentially protective lifestyle factors | |||
Frequent exercise | 0.78 (0.36–1.67) | 0.51 | |
Healthy food choices | 1.11 (0.50–2.44) | 0.80 | |
Sufficient sleep | 0.56 (0.22–1.43) | 0.23 | |
Frequent contact with children | 1.39 (0.68–2.86) | 0.37 | |
Potentially detrimental lifestyle factors | |||
Overweight/obesity | 2.68 (1.29–5.59) | 0.008* | |
Unfavorable fat distribution | 0.94 (0.46–1.94) | 0.87 | |
Smoking | 0.29 (0.06–1.28) | 0.10 | |
Regular consumption of alcohol | 0.93 (0.44–2.00) | 0.86 | |
Demographic characteristics | |||
Age ≥ 60 years | 1.53 (0.70–3.34) | 0.28# | |
Male sex | 1.34 (0.64–2.83) | 0.44# | |
Comorbidities | |||
Preexisting, chronic pulmonary disease | 2.45 (0.92–6.54) | 0.07# | |
Preexisting, chronic cardiovascular disease | 1.09 (0.33–3.58) | 0.89 | |
Presence of at least one cardiovascular risk factor | 0.83 (0.39–1.73) | 0.61 | |
Previous cancer | 1.08 (0.28–4.22) | 0.91 | |
Preexisting allergy | 0.81 (0.38–1.73) | 0.59 | |
Concomitant psychiatric disease | 5.99 (1.98–18.18) | 0.002# | |
Medication use | |||
ACE inhibitors | 2.02 (0.46–8.85) | 0.35 | |
RAAS inhibitors | 1.62 (0.61–4.31) | 0.33 | |
Statins | 0.34 (0.04–2.79) | 0.32 | |
Exposure to other viruses | |||
Frequent respiratory tract viral infections in the three years prior to COVID-19 | 1.11 (0.52–2.38) | 0.80 | |
Respiratory tract infection in the 4 weeks prior to COVID-19 | 1.09 (0.40–2.98) | 0.87 |
* significant with a false discovery rate of 10%.
# included in multivariate adjustment (Table 3).